Cette page a été traduite automatiquement et l'exactitude de la traduction n'est pas garantie. Veuillez vous référer au version anglaise pour un texte source.

A Clinical Study to Evaluate the Effects of Driscoll's Raspberries and Driscoll's Blackberries on Postprandial Glycemic Response, Satiety, and Consumer Appeal in Healthy Adults

12 novembre 2026 mis à jour par: Driscoll's

This is a decentralized, single-arm, within-subject crossover clinical study evaluating the effects of Driscoll's Raspberries and Driscoll's Blackberries on postprandial glycemic response, satiety, and consumer appeal in healthy adults aged 18-65 years. Forty participants will each consume three standardized breakfast meals - a raspberry-inclusive meal, a blackberry-inclusive meal, and a sugar-reference meal - in any order over a two-week period, wearing a continuous glucose monitor (CGM) throughout.

All study activities are conducted remotely at participants' homes. CGM data will be used to compute incremental area under the glucose-time curve (iAUC) over the two-hour postprandial window following each meal. Self-reported questionnaires will assess satiety, energy, digestive comfort, and sensory appeal following each meal condition.

Aperçu de l'étude

Type d'étude

Interventionnel

Inscription (Estimé)

40

Phase

  • N'est pas applicable

Contacts et emplacements

Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.

Coordonnées de l'étude

Lieux d'étude

    • Nevada
      • Las Vegas, Nevada, États-Unis, 89101
        • Citruslabs

Critères de participation

Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.

Critère d'éligibilité

Âges éligibles pour étudier

18 ans à 65 ans (Adulte, Adulte plus âgé)

Accepte les volontaires sains

Oui

Sexes éligibles pour l'étude

Tout

La description

Inclusion Criteria:

  • Be male or female.
  • Adult aged 18-65 years.
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease.
  • Willing and able to wear a CGM device continuously for the two-week study period.
  • Willing to consume three standardized breakfast meals over the two-week study period, each consumed after an overnight fast of at least eight hours, with a minimum of 24 hours between each standardized meal event.
  • Willing to purchase and eat fresh Driscoll's Raspberries and Driscoll's Blackberries from a local retailer using a sponsor-provided berry stipend for use in the standardized meals.
  • Have reasonable access to a retailer that sells Driscoll's-branded raspberries and blackberries.
  • Have access to a smartphone or computer with a reliable internet connection.
  • Willing to maintain the same diet and exercise regimen consistently throughout the study duration.
  • Willing and able to complete all required digital surveys via the Citruslabs study platform at Baseline, and at the end of the day following Meal 1, Meal 2, and Meal 3.
  • Resides in the United States.

Exclusion Criteria:

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
  • Anyone currently undergoing treatment for cancer, or have had a serious illness requiring hospitalization in the last 3 months.
  • Known or suspected allergy or hypersensitivity to raspberries, blackberries, or other berry species.
  • Known or suspected allergy, intolerance, or sensitivity to oats or gluten that would prevent consumption of the standardized oat-based meal component.
  • Current diagnosis of type 1 diabetes, type 2 diabetes, or prediabetes.
  • Current use of any medications or supplements known to significantly affect blood glucose levels, including but not limited to: insulin, metformin, GLP-1 receptor agonists, SGLT-2 inhibitors, sulfonylureas, or other glucose-lowering agents.
  • Known skin sensitivity to adhesives or prior documented adverse reaction to CGM sensors or similar transcutaneous monitoring devices.
  • Presence of implanted electronic devices (e.g., pacemaker, implantable cardioverter-defibrillator) that may be contraindicated with CGM device use, per the CGM manufacturer's specifications.
  • Pregnant, breastfeeding, or planning to become pregnant during the study period.
  • Anyone with a history of substance abuse.
  • Anyone who is currently a smoker or has been a smoker in the past three months.
  • Currently partaking in another research study or will be partaking in any other research study at any point during this study's duration.
  • History of an eating disorder currently requiring active clinical treatment.

Plan d'étude

Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.

Comment l'étude est-elle conçue ?

Détails de conception

  • Objectif principal: Traitement
  • Répartition: N / A
  • Modèle interventionnel: Affectation à un seul groupe
  • Masquage: Aucun (étiquette ouverte)

Armes et Interventions

Groupe de participants / Bras
Intervention / Traitement
Expérimental: Driscoll's Blackberries Arm

All participants complete all three meal conditions in any sequence.

Que mesure l'étude ?

Principaux critères de jugement

Mesure des résultats
Description de la mesure
Délai
Incremental Area Under the Glucose-Time Curve (iAUC) - Raspberry Meal vs. Sugar-Reference Meal
Délai: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of raspberry meal vs. sugar-reference meal

Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)
Incremental Area Under the Glucose-Time Curve (iAUC) - Blackberry Meal vs. Sugar-Reference Meal
Délai: Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

iAUC over the two-hour postprandial window following each standardized meal, as measured by CGM; within-subject contrast of blackberry meal vs. sugar-reference meal

Two-hour postprandial window following each of Meal 1, Meal 2, and Meal 3 (up to Day 14)

Mesures de résultats secondaires

Mesure des résultats
Description de la mesure
Délai
Change in Self-Reported Hunger
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Fullness
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Desire to Eat
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Energy Levels
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Digestive Comfort
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Change in Self-Reported Bloating
Délai: Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

Baseline and end of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Perceived Sweetness of Meal
Délai: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Palatability of Meal
Délai: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Motivation to Eat Healthier the Rest of the Day
Délai: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)
Self-Reported Overall Acceptability of Meal
Délai: End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Assessed via self-reported questionnaire administered through the Citruslabs digital study platform

End of day following Meal 1, Meal 2, and Meal 3 (up to Day 14)

Collaborateurs et enquêteurs

C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.

Parrainer

Collaborateurs

Dates d'enregistrement des études

Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.

Dates principales de l'étude

Début de l'étude (Estimé)

1 novembre 2026

Achèvement primaire (Estimé)

1 décembre 2026

Achèvement de l'étude (Estimé)

1 décembre 2026

Dates d'inscription aux études

Première soumission

12 novembre 2026

Première soumission répondant aux critères de contrôle qualité

12 novembre 2026

Première publication (Réel)

18 novembre 2026

Mises à jour des dossiers d'étude

Dernière mise à jour publiée (Réel)

18 novembre 2026

Dernière mise à jour soumise répondant aux critères de contrôle qualité

12 novembre 2026

Dernière vérification

1 novembre 2026

Plus d'information

Termes liés à cette étude

Autres numéros d'identification d'étude

  • DRISC-40019

Informations sur les médicaments et les dispositifs, documents d'étude

Étudie un produit pharmaceutique réglementé par la FDA américaine

Non

Étudie un produit d'appareil réglementé par la FDA américaine

Non

Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .

S'abonner